HPV Vaccine in Women with HIV
Part of Immune system & allergy, Infections clinical trials.
This study looks at how well the HPV vaccine works in women living with HIV and whether it helps make cervical cancer screening more accurate. If you are a woman with HIV between 21 and 40 years old and already part of certain other HIV studies, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman living with HIV, between 21 and 40 years old.
- You are already enrolled in a specific HIV study (like PHACS, SMARTT, AMP Up, or HOPE).
- You are willing to give consent and let the researchers access your medical records and other study data.
- You are not currently pregnant (per your report) and do not have active cervical precancer requiring colposcopy.
- You do not have a bleeding disorder or have had a hysterectomy (removal of the cervix).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how well the Gardasil 9 HPV vaccine works in people assigned male at birth, including those with HIV and those taking hormone therapy. Results could help protect against HPV-related cancers.
This trial tests whether giving a lower dose of the HPV vaccine can still be effective and safe for women living with HIV. It may be helpful if you need HPV protection and the study’s dose schedule could reduce vaccine burden.
This study tests how well the HPV vaccine works in women and teens. It's for those who are willing to get an HPV test and haven't already had all 3 doses of the vaccine.
This trial offers a take-home HPV test kit so women living with HIV can check for cervical cancer risk without a clinic visit. It aims to make screening easier and more convenient.
This study tests different ways to screen for HPV (a virus linked to cervical cancer) in women living with HIV. The goal is to find the best, most practical screening approach to catch cervical problems early.
This trial tests whether adding HPV vaccination to the cervical cancer screening plan—while you get care at HIV (ARV) clinics—improves prevention of cervical problems. It focuses on women with HIV aged 25–35 to help reduce HPV-related cervical disease over time.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.